KP415 oral capsule
KP415.E01
Phase 3 small_molecule completed
Quick answer
KP415 oral capsule for ADHD is a Phase 3 program (small_molecule) at ZEVRA THERAPEUTICS, INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- ZEVRA THERAPEUTICS, INC.
- Indication
- ADHD
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed